Ocular Complications after Hand Transplantation

  • Daniele Veritti
  • Lanzetta Marco


To our knowledge, there are no publications regarding ocular complications following hand transplantation. The reasons are that this is a recently developed practice, cases are numerically limited and follow-up is necessarily short. However, one can presume that these complications can be considered comparable with the wider cases available for liver, kidney and heart transplant patients undergoing similar immunosuppressive therapy.


Diabetic Retinopathy Proliferative Diabetic Retinopathy Central Serous Chorioretinopathy Ocular Complication Neovascular Glaucoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lanzetta M, Petruzzo P, Vitale G et al (2004) Human hand transplantation: what have we learned? Transplant Proc 36:664–668PubMedCrossRefGoogle Scholar
  2. 2.
    Shimmyo A, Miyazaky S, Onoe S et al (1997) Ocular complications after renal transplantation. Nippon Ganka Gakkai Zasshi 101:220–226PubMedGoogle Scholar
  3. 3.
    Veenstra DL, Best JH, Hornberg J et al (1999) Incidence and cost of steroid side-effects after renal transplantation. Am J Kidney Dis 33:829–839PubMedGoogle Scholar
  4. 4.
    Black RL, Oglesby RB, von Sallmann L, Bunim JJ (1960) Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 174:150–155Google Scholar
  5. 5.
    Nishimoto K, Sasaki K, Yamamura T et al (1992) Cataract in renal transplantation recipients with combination cyclosporine treatment. Lens Eye Toxic Res 9:455–467PubMedGoogle Scholar
  6. 6.
    Jobling AI, Augusteyn RC (2002) What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 85:2:61–75PubMedCrossRefGoogle Scholar
  7. 7.
    Haimovici R, Koh S, Gagnon DR, Lehrfeld T (2004) Risk factors for central serous chorioretinopathy, a case control study. Ophthalmology 111:244–249PubMedCrossRefGoogle Scholar
  8. 8.
    Bandello F, Incorvaia C, Rosa N et al (2002) Bilateral central serous chorioretinopathy in a patient treated with systemic corticosteroids for non-Hodgkin’s lymphoma. Eur J Ophthalmol 2:123–126Google Scholar
  9. 9.
    Levy J, Marcus M, Belfair N et al (2005) Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy. Can J Ophthalmol 40:217–221Google Scholar
  10. 10.
    Jampol LM, Weired R, Yannuzzi L (2002) Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology 109:1765–1766PubMedCrossRefGoogle Scholar
  11. 11.
    Jampol LM, Yanuzzi LA, Weinreb RN (2005) Glaucoma and intravitreal steroids. Ophthalmology 112:1325–1326PubMedCrossRefGoogle Scholar
  12. 12.
    Shutter LA, Green JP, Newmann NJ et al (1993) Cortical blindness and white matter lesion in a patient receiving FK506 after liver transplantation. Neurology 43:2417–2418PubMedGoogle Scholar
  13. 13.
    Devine SM, Newmann NJ, Siegal JL et al (1996) Tacrolimus (FK506) induced cerebral blindness following bone marrow transplantation. Bone Marrow Transplant 18:569–572PubMedGoogle Scholar
  14. 14.
    Steg RE, Kessinger A, Wszolek ZK (1999) Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 23:959–952PubMedCrossRefGoogle Scholar
  15. 15.
    Brazis PW, Spivey JR, Bolling JP, Steers JL (2000) A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol 536–538Google Scholar
  16. 16.
    Lanzetta P, Monaco P (2004) Major ocular complications after organ transplantation. Transplant Proc 3046–3048Google Scholar
  17. 17.
    Ishida H, Mitamura T, Takahashy Y et al (1997) Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. Toxicology 123:167–175PubMedCrossRefGoogle Scholar
  18. 18.
    Zoja C, Furci L, Ghilardi F et al (1986) Cyclosporin-induced endothelial cell injury. Lab Invest 55:455–462PubMedGoogle Scholar
  19. 19.
    O’Riordan JM, FitzSimon S, O’Connor M, McCann SR (1994) Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine. Bone Marrow Transplant 13:101–104PubMedGoogle Scholar
  20. 20.
    Moon SJ, Mieler WF (2003) Retinal complications of bone marrow and solid organ transplantation. Curr Opin Ophthalmol 14:433–442PubMedCrossRefGoogle Scholar
  21. 21.
    Openshaw H, Slatkin NE, Smith E (1997) Eye movement disorders in bone marrow transplant patients on cyclosporine and ganciclovir. Bone Marrow Transplant 19:503–505PubMedCrossRefGoogle Scholar
  22. 22.
    Nakamura T, Sasaki H, Nagai K et al (2003) Influence of cyclosporin on steroid-induced cataracts after renal transplantation. Jpn J Ophthalmol 47:254–259PubMedCrossRefGoogle Scholar
  23. 23.
    Guembel HO, Ohroff C (1997) Opportunistic infections of the eye in immunocompromised patients. Ophthalmologica 2:123–126Google Scholar
  24. 24.
    Ng P, McCluskey P, McCaughan G et al (1998) Ocular complications of heart, lung and liver transplantation. Br J Ophthalmol 82:423–42PubMedCrossRefGoogle Scholar
  25. 25.
    Lalezari JP, Friedberg DN, Bisset J et al (2002) High dose oral ganciclovir treatment for cytomegalovirus retinitis. J Clin Virol 24(1–2):67–77PubMedCrossRefGoogle Scholar
  26. 26.
    Martin DF, Sierra-Madero J, Walmsley S et al (2002) A controlled trial of valganciclovir induction therapy for cytomegalovirus retinitis. N Engl J Med 346:1119PubMedCrossRefGoogle Scholar
  27. 27.
    Mehta S (2004) Major ocular complications after organ transplantation. Indian J Ophthalmol 52:255–256PubMedGoogle Scholar
  28. 28.
    Obayashi PA (2004) Posttransplant diabetes mellitus: cause, impact, and treatment options. Nutr Clin Pract 19:165–171PubMedCrossRefGoogle Scholar
  29. 29.
    Roozbeh J, Mehdizadeh AR, Razmkon A, Malek-Hosseini SA (2005) Incidence of posttransplantation diabetes mellitus in kidney transplantation: a single-center experience. Transplant Proc 37:3095–3097PubMedCrossRefGoogle Scholar
  30. 30.
    Jindal RM, Sidner RA, Milgrom ML (1997) Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 16:242–257PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Daniele Veritti
    • 1
  • Lanzetta Marco
    • 2
    • 3
    • 4
    • 5
    • 6
  1. 1.Department of OphthalmologyUniversity of UdineUdineItaly
  2. 2.Italian Institute of Hand Surgery MonzaMilanItaly
  3. 3.Hand Surgery and Reconstructive Microsurgery UnitSan Gerardo HospitalMonza, MilanItaly
  4. 4.University of Milan-BicoccaMilanItaly
  5. 5.University of CanberraAustralia
  6. 6.International Hand and CompositeTissue Allograft SocietyAustralia

Personalised recommendations